ursolic acid has been researched along with Angiogenesis, Pathologic in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Chen, P; Li, J; Li, M; Liang, X; Wu, Q; Zeng, Z | 1 |
| Abbasi, BA; Ahmad, R; Alam, MM; Ali, B; Badshah, H; Iqbal, J; Kanwal, S; Khalil, AT; Mahmood, T; Shah, SA | 1 |
| Jiang, Z; Wu, Y; Xiong, H; Yang, M; Yao, J; Zhou, J | 1 |
| Chen, Y; Hong, Z; Lin, J; Peng, J; Sferra, TJ; Wei, L | 1 |
| Agrawal, SS; Alhaider, AA; Saraswati, S | 1 |
| Bai, H; Cai, J; Chen, ZW; Cheng, X; Huang, D; Jiang, J; Jin, H; Pi, J; Wu, C; Yang, F | 1 |
| Huang, L; Li, Y; Miao, L; Satterlee, AB; Wu, Y; Yao, J; Zhou, J | 1 |
| Huang, JJ; Shan, JZ; Xuan, YY; Zhang, Q | 1 |
| Gao, JL; He, BC; He, TC; Huang, EY; Ji, X; Jiang, W; Lv, GY; Shou, QY; Shui, YM | 1 |
| Cheng, W; Dahmani, FZ; Wu, Y; Xiong, H; Yao, J; Yin, L; Zhang, J; Zhou, J | 1 |
| Kanjoormana, M; Kuttan, G | 1 |
| Chang, NC; Chen, TL; Chen, YH; Fong, TH; Huang, CY; Lee, AW; Lin, FY; Shih, CM; Tsao, NW | 1 |
| Abbasi, T; Ho, PC; Hui, KM; Kapoor, S; Kumar, AP; Li, F; Nema, T; Rajendran, P; Sethi, G; Shanmugam, MK; Sharma, A; Vali, S | 1 |
| Chang, CD; Liao, MH; Lin, PY; Shih, WL; Wu, HY; Yu, FL | 1 |
| Castilla, V; de Nicolás, R; Egido, J; González-Cabrero, J; Gutierrez, C; Pozo, M | 1 |
| Chung, HY; Kim, KW; Lee, HY; Sohn, KH; Yi, SY; Young, HS | 1 |
1 review(s) available for ursolic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; Humans; Neovascularization, Pathologic; Signal Transduction; Triterpenes; Ursolic Acid | 2018 |
15 other study(ies) available for ursolic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival.
Topics: Apoptosis; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Endometriosis; Endometrium; Female; Humans; Neovascularization, Pathologic; Stromal Cells; Triterpenes; Ursolic Acid; Vascular Endothelial Growth Factor A | 2020 |
pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Liberation; Drug Screening Assays, Antitumor; Hep G2 Cells; Heparin; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Neovascularization, Pathologic; Particle Size; Polymers; Structure-Activity Relationship; Surface Properties; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2019 |
Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Colorectal Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2013 |
Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Body Weight; Carcinoma, Ehrlich Tumor; Caspase 3; Caspase 9; Cell Line, Tumor; Cytokines; Down-Regulation; Kaplan-Meier Estimate; Mice; Mitochondria; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Triterpenes; Ursolic Acid; Vascular Endothelial Growth Factor A | 2013 |
Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Chitosan; Chorioallantoic Membrane; Drug Carriers; Human Umbilical Vein Endothelial Cells; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Triterpenes; Ursolic Acid; Wound Healing; Xenograft Model Antitumor Assays | 2016 |
Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy.
Topics: Angiogenesis Inhibitors; Animals; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Drug Delivery Systems; Female; Heparin, Low-Molecular-Weight; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Nanostructures; Neoplasms; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, sigma; Triterpenes; Ursolic Acid; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cycloheximide; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Organoplatinum Compounds; Oxaliplatin; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Triterpenes; Ursolic Acid; Vascular Endothelial Growth Factor A | 2016 |
Hypoxia pathway and hypoxia-mediated extensive extramedullary hematopoiesis are involved in ursolic acid's anti-metastatic effect in 4T1 tumor bearing mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Female; Hematopoiesis, Extramedullary; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Signal Transduction; Triterpenes; Ursolic Acid; Von Hippel-Lindau Tumor Suppressor Protein | 2016 |
Anti-angiogenic activity and antitumor efficacy of amphiphilic twin drug from ursolic acid and low molecular weight heparin.
Topics: Angiogenesis Inhibitors; Animals; Anticoagulants; Body Size; Collagen; Drug Combinations; Female; Glycoconjugates; Heparin, Low-Molecular-Weight; Human Umbilical Vein Endothelial Cells; Humans; Injections, Intravenous; Laminin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Nanoparticles; Neovascularization, Pathologic; Particle Size; Proteoglycans; Surface-Active Agents; Triterpenes; Tumor Burden; Ursolic Acid | 2017 |
Antiangiogenic activity of ursolic acid.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Cytokines; Endothelial Cells; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triterpenes; Umbilical Veins; Ursolic Acid; Vascular Endothelial Growth Factor A | 2010 |
Ursolic acid induces allograft inflammatory factor-1 expression via a nitric oxide-related mechanism and increases neovascularization.
Topics: Angiogenesis Inducing Agents; Animals; Calcium-Binding Proteins; Cell Line; Disease Models, Animal; Endothelial Cells; Gene Expression; Hindlimb; Humans; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Microfilament Proteins; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Triterpenes; Ursolic Acid | 2010 |
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; eIF-2 Kinase; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Interleukin-6; Janus Kinase 2; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappaB-Inducing Kinase; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proteomics; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; STAT3 Transcription Factor; Triterpenes; Tumor Necrosis Factor-alpha; Ursolic Acid; Xenograft Model Antitumor Assays | 2011 |
Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flavones; Fluorescent Antibody Technique; Glucose-6-Phosphate Isomerase; Humans; Immunoprecipitation; Liver Neoplasms; Luciferases; Lung Neoplasms; Male; Matrix Metalloproteinase 3; Mice; Mice, Nude; Neovascularization, Pathologic; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; rhoA GTP-Binding Protein; Signal Transduction; Transforming Growth Factor beta; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 2013 |
Ursolic acid inhibits neointima formation in the rat carotid artery injury model.
Topics: Animals; Carotid Artery Injuries; Carotid Artery, Common; Cell Proliferation; Cells, Cultured; Cyclooxygenase Inhibitors; Disease Models, Animal; Follow-Up Studies; Hyperplasia; Immunohistochemistry; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Triterpenes; Tubulin; Tunica Intima; Ursolic Acid; Vimentin | 2006 |
Anti-angiogenic activity of triterpene acids.
Topics: Allantois; Animals; Chick Embryo; Chorion; Dose-Response Relationship, Drug; Neovascularization, Pathologic; Oleanolic Acid; Triterpenes; Ursolic Acid | 1995 |